Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients
Phase 1
- Conditions
- Chronic Hepatitis C Virus Infection
- Interventions
- Drug: CHRONVAC-C®
- First Posted Date
- 2007-11-26
- Last Posted Date
- 2010-02-10
- Lead Sponsor
- Tripep AB
- Target Recruit Count
- 12
- Registration Number
- NCT00563173
- Locations
- 🇸🇪
I73 Department of Infectious Diseases, Karolinska Institute, Karolinska University Hospital, Huddinge, Stockholm, Sweden
🇸🇪Department of Gastroenterology and Hepatology, Karolinska University Hospital, Solna, Stockholm, Sweden
News
No news found